Answer
Yes, concomitant administration of cariprazine hydrochloride (Reagila) with strong or moderate CYP3A4 inducers is contraindicated.
Sources for this answer
- Reagila 1.5 mg 3 mg 4.5 mg 6 mg hard capsulesGedeon Richter (UK) Ltd · emc · SmPC §4.3 Contraindications · Version 7Document updated
Sources checked